Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

Hvorfor velge oss? Tradisjonell varehandel står ovenfor store utfordringer i konkurranse med veksten i netthandel. Spesielt presserende er utfordringer i forhold til kjøpsopplevelse, effektivitet og lønnsomhet. ​ Vårt fokus i Qtime er å hjelpe varehandelen til å løse nettopp disse utfordringene. Gi kundene dine den beste handleopplevelsen, med fremtidens kundestrømsverktøy.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

An employee management system that´s designed to be easy to use. By thinking differently and smarter than our competitors we are making an employee management system that is easy to use, especially for elderly users. And the system is not complicated. We are focusing on that our typical customer is both 20 and 60 years old. Therefore is it important for us to listen to them, so we can make a system that is understandable for them. By getting satisfied customers, we will be the preferred system for small and medium-sized businesses. We are providing a web-based system that is available on all devices. In our system, you find timesheets, deviation, weekly plans/schedules, resource-planner, groups, CRM, newsfeeds, to-do-list, use on projects, travel logs, and many more tools for communication and registration. We want to make a smart and effective day for small and medium businesses. KPI - Key Performance Indicator:- MVP - Minimum Viable Product- 20 costumers- Founding from Innovation Norway (marked clarification)- 2016 revenue: 318.000NOK

“SevenSix is a learning and development platform to empower tennis players through their careers. It will be a holistic service, transforming data into knowledge about strengths and opportunities, to optimize how the player exercises, competes, eats, sleeps, thinks and is motivated. This is done by gathering, transforming, combining, and visualizing ALL relevant data, bridging science and technology combined with methodology and experience. ”MVBP is ready and is beeing tested on the national team of tennis and Stavanger Tennisklubb. The development is supported by Microsoft and Capgemini.SevenSix will be distributed to 100 million tennis players with membership in Tennis Federations.

Vi forenkler hverdagen Rubic ble etablert i April 2014 med mål om å forenkle hverdagen for lag og foreninger i Norge. Vår ambisjon er å bli markedsleder i Norge for medlemsbaserte organisasjoner. Vi leverer ekspertise og systemer innenfor privat-, offentlig- og frivillig sektor. Drift smartere, mer tid Vi hjelper din forening med å drive profesjonelt og yte bedre service til deres medlemmer.

Think Outside is now Mitta AS, a subsidiary fully owned by Mitta Oy. Mitta will be offering geodata monitoring and measurement services to the Norwegian market, bridging the growth of the Finnish and Swedish Mitta companies to new Norwegian customers. For us at Mitta, accurate and reliable positioning is extremely important, as it is a basic prerequisite for spatial information. High-quality input data means cost-effectiveness in design, construction and monitoring, regardless of the customer's industry. Mitta is the market leader as a producer and processor of terrain information in the infrastructure sector in Finland and Sweden. Our customers operate in the construction value chain from design to production.

Norwegian wearable company that specializes in payments using tokenization technology through NFC. Berg is the first company to deliver classic watches to the market that customers can pay with and more. We are currently looking for strategic investors that can help us bring our products to the masses. Contact our CEO, Paal Friele Grung through paal@bergwatches.com for more.

Building a "børs"  for the worlds non for profit organisation in Oslo. Oslo Philanthropic Exchange is a non-profit foundation. Our mission is to bring the best practice from the global capital markets to raise philanthropic funding more efficiently. Our goal is to contribute to higher impact of philanthropic capital. The OPX Solution addresses the inefficient funding of the non-profit sector and the lack of standardised, transparent and comparable data. By applying best practice from the capital markets for listing of non-profit organisations and reporting requirements as well as leveraging existing infrastructures, we standardise and digitalise to increase efficiency, transparency, accountability and accessibility. The OPX Solution represent the complete value chain of finding, filtering, funding and following the world’s non-profit organisations.

Game-changing technology for structural integrity monitoring. The Ferrx FEMM (Ferrx ElectroMagnetic Method) has been developed and tested for 2 decades, first by SINTEF and since 2005 by Ferrx. The method has provided unique features for the condition monitoring of steel structures. Material deterioration can be directly measured and early warning of risk for fatigue can be established long before any crack is detectable. Furthermore, the same sensors can also measure changes in metal loss, and thus provide for non-intrusive monitoring of internal corrosion and erosion in pipes. During the last years, instrumentation technology has been industrialized and the first commercial systems have been delivered and installed. Different types of instrumentation systems are available both for onshore and offshore/subsea applications. The industrialization, marinization, and production of the instrumentation systems are being done in cooperation with the most specialized suppliers. Ferrx is an independent company located in Trondheim, Norway with the business idea to provide the FEMM technology for different onshore and offshore markets to monitor the actual condition of steel structures and thus prevent loss of assets and pollution of the environment. The FEMM is protected by 2 patents and all rights are vested in Ferrx. The system for riser inspection has been qualified by DNV-GL in accordance with DNV-RP-A203 Technology Qualification.

Greensight - grønn energiomstilling gjort enkelt.Mangelen på oppdatert og lett tilgjengelig høykvalitets informasjon om grønne energiløsninger, næringer og  markeder hindrer bedrifter og kommuner fra å velge bærekraftige og framtidsrettede løsninger. Veldig mange beslutningstakerne har verken tid eller kunnskap til å vurdere nye løsninger, og innovative, grønne og lønnsome løsninger blir ofte oversett. Greensight jobber med å bygge beslutningstøtteverktøy basert på oppdatert og kvalitetskontrollert informasjon om grønn teknologi, løsninger og markeder. Dette gir brukere mulighet til å få tilgang til gode, oppdaterte og visuelle data og analyser som er tilpasset brukerens prosjekter og virksomhet.Greensight AS er et datterselskap av Greenstat AS.

"Sammen om en jobb" (Together for a Job) is a Norwegian NGO running a mentor program between young immigrants and elderly Norwegians. The program has three principal aims:- transfer skills and knowledge from elderly people at the end of their professional careers to young immigrants just about to start theirs - provide a meaningful activity for people entering into retirement- support young immigrants in their job search- create relationships between different generations and cultures

Lawbotics has developed an innovative tool called LEXOLVE to streamline parts of the legal processes that take place in all companies – namely the creation of legal contracts and other documents. By letting legal experts automate their own legal documents using our software, we make it easy for businesses to increase the quality of their legal documents while saving a significant amount of time and resources.

We deliver production and distribution tools for content in the story format, allowing customers to leverage the format on their own platforms or web pages. Adding stories to your webpage, listing or email is often a lot easier than people think. Most of our users are able to embed stories by simply copying and pasting a snippet.

NORIGIN MEDIA is a TV Everywhere company, which enables multi-screen and OTT services for carriers, broadcasters, and content owners. The Scandinavian company offers a complete multi-screen application suite and a Live TV hosting headend capacity as primary products. NORIGIN MEDIA is reinventing how people watch TV. Join the technical revolution on how people will consume TV content in the years to come. You will architect and develop user experiences that will reach millions of TV users on Smartphones, Tablets, PCs, Connected TV, and Game Consoles.